By Julia Karow
This article was originally published Aug. 2.
Complete Genomics plans to raise up to $86.25 million in an initial public offering of its common stock, according to documents filed with the US Securities and Exchange Commission last week.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
